Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
Stroke 51:533-541, Shahjouei, S.,et al, 2020
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
Stroke 51:1616-1619, Beharry, J.,et al, 2020
Stroke Reperfusion Therapy Following Dabigatran Reversal with Idarucizumab in a National Cohort
Neurol 94:e1968-e1972, Barber, P.A.,et al, 2020
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 48:2031-2033, Tsivgoulis, G. & Safouris, A., 2017
Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
Ann Neurol 74:266-274, Mazya, M.V.,et al, 2013
Percutaneous Vascular Interventions for Acute Ischemic Stroke
Stroke 42:e31-e32, ORourke,K.,et al, 2011
Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 67:559-563, Prabhakaran,S., et al, 2010
Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009
Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008
Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008
Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008
Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008
Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007
Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis
Stroke 32:2310-2317, Wassay,M.,et al, 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996
Guidelines for the Management of Patients with Acute Ischemic Stroke
Stroke 25:1901-1914, Adams,H.P.,et al, 1994
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Intra-arterial Thrombolytic Therapy Improves Outcome in Patients with Acute Vertebrobasilar Occlusive Disease
Stroke 19:1216-1222, Hacke,W.,et al, 1988
Heparin-Urokinase Treatment in Aseptic Dural Sinus Thrombosis
Arch Neurol 38:431-435, DiRocco,C.,et al, 1981
Treatment of Strokes
NEJM 281:594, 1969,, Browne,T.,et al, 1969